Picture of PharmaSGP Holding SE logo

PSG PharmaSGP Holding SE Share Price

0.000.00%
de flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m+4.99%
3m-10.5%
6m-6.24%
1yr-24.54%
Volume Change (%)
10d/3m+50.91%
Price vs... (%)
52w High-13.47%
50d MA+2.87%
200d MA-3.41%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)12.08
PEG Ratio (f)0.9
EPS Growth (f)15.47%
Dividend Yield (f)3.17%
Valuation (ttm)IndustryMarket
Price to Book Value5.69
Price to Tang. Bookn/a
Price to Free Cashflow9.69
Price to Sales2.37
EV to EBITDA7.91

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital23.5%
Return on Equity46.41%
Operating Margin24.48%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m62.5763.2565.3485.82101.1110.55118.710.78%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+12.67-29.44+0.28+11.59+25.03+12.76+16.29n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of PharmaSGP Holding SE EPS forecast chart

Profile Summary

PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
March 20th, 2020
Public Since
June 19th, 2020
No. of Employees
89
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
de flag iconXETRA
Shares in Issue
11,990,213

PSG Share Price Performance

Upcoming Events for PSG

Preliminary Q3 2024 PharmaSGP Holding SE Earnings Release

Q3 2024 PharmaSGP Holding SE Interim Management Statement Release

FAQ